e-learning
resources
Munich 2014
Monday, 08.09.2014
Diagnosis, imaging and surgery for thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
F. Yildirim, M. Türk, U. O. Akdemir, I. Tastepe, A. S. Yurdakul (Ankara, Turkey)
Source:
International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session:
Diagnosis, imaging and surgery for thoracic tumours
Session type:
Thematic Poster Session
Number:
2772
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Yildirim, M. Türk, U. O. Akdemir, I. Tastepe, A. S. Yurdakul (Ankara, Turkey). Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?. Eur Respir J 2014; 44: Suppl. 58, 2772
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC)
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept